CHF46.62
5.70% today
SIX Swiss Exchange, Apr 04, 05:30 pm CET
ISIN
CH0012530207
Symbol
BANB
Sector
Industry

Bachem Holding Stock price

CHF46.62
-9.13 16.38% 1M
-22.68 32.73% 6M
-11.28 19.48% YTD
-37.73 44.73% 1Y
-60.28 56.39% 3Y
+6.42 15.97% 5Y
+35.88 334.08% 10Y
SIX Swiss Exchange, Closing price Fri, Apr 04 2025
-2.82 5.70%
ISIN
CH0012530207
Symbol
BANB
Sector
Industry

Key metrics

Market capitalization CHF3.71b
Enterprise Value CHF3.61b
P/E (TTM) P/E ratio 30.83
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.97
P/S ratio (TTM) P/S ratio 6.12
P/B ratio (TTM) P/B ratio 2.66
Dividend yield 1.72%
Last dividend (FY24) CHF0.85
Revenue growth (TTM) Revenue growth 4.84%
Revenue (TTM) Revenue CHF605.26m
EBIT (operating result TTM) EBIT CHF131.94m
Free Cash Flow (TTM) Free Cash Flow CHF-126.67m
EPS (TTM) EPS CHF1.60
P/E forward 28.71
P/S forward 5.25
EV/Sales forward 5.12
Show more

Is Bachem Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Bachem Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Bachem Holding forecast:

5x Buy
50%
5x Hold
50%

Analyst Opinions

10 Analysts have issued a Bachem Holding forecast:

Buy
50%
Hold
50%

Financial data from Bachem Holding

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
605 605
5% 5%
100%
- Direct Costs 423 423
6% 6%
70%
183 183
3% 3%
30%
- Selling and Administrative Expenses - -
- Research and Development Expense 11 11
3% 3%
2%
175 175
6% 6%
29%
- Depreciation and Amortization 43 43
16% 16%
7%
EBIT (Operating Income) EBIT 132 132
3% 3%
22%
Net Profit 120 120
8% 8%
20%

In millions CHF.

Don't miss a Thing! We will send you all news about Bachem Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.

Head office Switzerland
CEO Thomas Meier
Employees 2,207
Founded 2003
Website www.bachem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today